SCHEMBL6501458

SCHEMBL6501458

COC(=O)NC(=S)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
HPGD P15428 4/20 0.55
LMNA P02545 3/20 0.55
ALOX15 P16050 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
HTT P42858 2/20 0.47
GAA P10253 2/20 0.47
MGLL Q99685 1/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
EPHX1 P07099 1/20 0.43
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1816064 0.82 GAA (0.51) ALDH1A1HPGDLMNAHSD17B10SMN1; SMN2
SCHEMBL6885505 0.81 TSHR (0.58) ALDH1A1LMNAALOX15HSD17B10TSHR
SCHEMBL5365743 0.79 EPHX1 (0.55) ALDH1A1HPGDHSD17B10TSHRSMN1; SMN2
SCHEMBL1701693 0.79 ALDH1A1 (0.52) ALDH1A1HPGDALOX15HSD17B10TSHR
SCHEMBL3062971 0.78 POLB (0.54) ALDH1A1HPGDLMNAALOX15HSD17B10
SCHEMBL10814700 0.78 TSHR (0.54) ALDH1A1HPGDLMNAALOX15HSD17B10
SCHEMBL3077377 0.77 ALDH1A1 (0.67) ALDH1A1ALOX15HSD17B10SMN1; SMN2NPC1
SCHEMBL11470090 0.77 ALDH1A1 (0.50) ALDH1A1HPGDALOX15HSD17B10TSHR
SCHEMBL14322322 0.76 TSHR (0.52) ALDH1A1HPGDLMNAALOX15HSD17B10
SCHEMBL3077991 0.75 ALDH1A1 (0.59) ALDH1A1HPGDLMNAALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080113-A1 Medicinal compositions TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080113-A1 Medicinal compositions TNF, TRAF6, MMP8 ALDH1A1 3345/4885HPGD 308/4885LMNA 3321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.